In Vitro Technologies partners with Novus Biologicals in ANZ


Thursday, 02 July, 2015

In Vitro Technologies has been announced as the distributor for Novus Biologicals in Australia and New Zealand as of 1 July 2015.

Novus Biologicals, a Bio-Techne brand, is committed to providing researchers with a comprehensive range of high-quality antibodies. The company’s aim is to provide quality tools to accelerate the bioscience research community.

It has been said that the partnership will enable increased efficiencies through consolidation of all Bio-Techne’s consumable products through one channel, In Vitro Technologies. Users can purchase Novus Biologicals, R&D Systems, Tocris and Boston Biochem products all from one place.

In Vitro Technologies says its extensive life science portfolio provides the company with the technical expertise to empower users through the evolution of their research. Users are encouraged to talk to one of the company’s applications specialised product managers and build a customised solution from its cell biology portfolio, including brands such as ATCC, HyClone, Falcon and Corning in addition to the Bio-Techne range.

Related News

Novel glycopeptide antibiotic candidate shows promise

Researchers have discovered a new type of glycopeptide antibiotic known as saarvienin A, found to...

Why a gluten-free diet fails in some coeliac patients

Abnormal immune cells are driving ongoing intestinal inflammation that causes symptoms like...

Giving rotavirus vaccine at birth benefits gut bacteria

Babies who receive a RV3-BB rotavirus vaccine at birth appear to show higher levels of good...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd